Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment crawled time : 13:00 save search
Health Canada Approves KEYTRUDA as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
MRK | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
health treatment for canada advanced keytruda
Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
ONCT | News | $8.97 4.3% 4.12% 4.5K
|
Health Technology
| Email alert
Add to watchlist
onct-534 first cancer treatment for study
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
EVO | News | $7.15 -0.7% 19K
|
Manufacturing
|
| O: 0.42%
H: 0.0%
C: 0.0%
partnership fibrosis
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ABVC | News | $0.9899 -5.72% -6.07% 160K
|
Wholesale Trade
|
| O: 2.68%
H: 3.48%
C: -11.3%
treatment biopharma royalties global for agreement
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea & Vomiting at the Upcoming ASPAN 2024 National Conference in Orlando, Florida
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
EGRX | $4.63 3.35% 3.24% 60K
|
Health Technology
|
| O: -8.14%
H: 19.55%
C: 18.18%
conference treatment pharmaceuticals for trial response
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: 0.0%
qulipta abbvie treatment for migraine
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
Published: 2024-04-11 (Crawled : 13:00) - globenewswire.com
CADL | $5.17 -5.31% -5.61% 520K
|
|
| O: 25.49%
H: 23.75%
C: 13.75%
can-2409 fda drug cancer pancreatic treatment designation for therapeutics
PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
Published: 2024-04-09 (Crawled : 13:00) - globenewswire.com
PRFX | News 0 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: 15.88%
H: 29.44%
C: -23.35%
treatment for
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
Published: 2024-03-26 (Crawled : 13:00) - globenewswire.com
VIRI | $0.4393 -2.36% -2.41% 59K
|
Health Technology
|
| O: 4.41%
H: 8.05%
C: -12.31%
patent antiviral international publication treatment therapeutics
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
Published: 2024-03-21 (Crawled : 13:00) - globenewswire.com
FEMY | News | $1.33 1.53% 1.5% 160K
|
Manufacturing
|
| O: 0.0%
H: 0.56%
C: -4.44%
treatment
LiqTech Secures Order from NESR for Produced Water Treatment Pilot Unit for Middle East Operations
Published: 2024-03-19 (Crawled : 13:00) - prnewswire.com
NESR | $9.0 -36.31% 500K
|
Industrial Services
|
| O: -1.27%
H: 3.87%
C: 2.58%
LIQT | $2.67 -2.91% -3.0% 10K
|
Producer Manufacturing
|
| O: -4.55%
H: 8.57%
C: 1.9%
water treatment order pilot
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada
Published: 2024-03-18 (Crawled : 13:00) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: -0.73%
H: 3.31%
C: 0.74%
elyxyb drug patent company health approval review treatment canada migraine submission
Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis
Published: 2024-03-15 (Crawled : 13:00) - prnewswire.com
GLMD | $0.3787 -0.41% 18K
|
Health Technology
|
| O: 17.48%
H: 0.0%
C: -25.59%
mgl-3196 patent liver treatment fibrosis grant aramchol nash
Oncternal Participating in Virtual Fireside Chat with Key Opinion Leader on Treatment Landscape & New Treatment Options for Prostate Cancer
Published: 2024-03-15 (Crawled : 13:00) - globenewswire.com
ONCT | News | $8.97 4.3% 4.12% 4.5K
|
Health Technology
|
| O: -4.32%
H: 8.26%
C: 7.19%
cancer treatment key
Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024
Published: 2024-03-13 (Crawled : 13:00) - globenewswire.com
FEMY | News | $1.33 1.53% 1.5% 160K
|
Manufacturing
|
| O: -5.76%
H: 12.78%
C: 0.56%
treatment
MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment
Published: 2024-03-12 (Crawled : 13:00) - globenewswire.com
MGRX | $0.286 -4.64% -4.86% 78K
|
|
| O: -2.97%
H: 18.53%
C: 5.15%
kyzatrex fda approved treatment therapy
TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment
Published: 2024-03-11 (Crawled : 13:00) - globenewswire.com
RNAZ | $0.49 -2.39% -2.45% 110K
|
Professional, Scientific, and T...
|
| O: 2.86%
H: 0.0%
C: -11.14%
report genomics cancer treatment technology therapeutics
Hawkins, Inc. Expands Water Treatment Footprint with Acquisition of Industrial Research Corporation
Published: 2024-03-11 (Crawled : 13:00) - globenewswire.com
HWKN 4 | $74.59 -0.15% -0.15% 360K
|
Distribution Services
|
| O: 0.69%
H: 2.87%
C: 2.56%
water corporation treatment acquisition research
STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
Published: 2024-03-07 (Crawled : 13:00) - globenewswire.com
SSKN | $0.56 5.15% 4.89% 75K
|
Health Technology
|
| O: -0.95%
H: 1.85%
C: -1.91%
initiative treatment sciences skin
Madrigal Pharmaceuticals Announces EMA Validation of its Marketing Authorization Application for Resmetirom for the Treatment of NASH/MASH with Liver Fibrosis
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
MDGL | $212.33 -4.47% -4.68% 620K
|
Health Technology
|
| O: -0.86%
H: 2.04%
C: 1.66%
liver authorization treatment fibrosis pharmaceuticals ema application
Gainers vs Losers
| 68% | 32% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.